Genetic specification of malignant hyperthermia susceptibility is warranted for assessing fatigue, depression, and exercise intolerance
Braz. J. Anesth. (Impr.); 73 (6), 2023
Results: 3
Hipertermia maligna
Rev. chil. anest; 50 (1), 2021
Carriers of malignant hyperthermia (MH), a subclinical metabolic myopathy, respond differently to the general population in response to triggering agents, such as volatile anesthetics and succinylcholine. Its incidence ranges from 1:10,000 to 1:250,000 anesthesias. Using etiological treatment, the curren...
Estado actual del estudio de susceptibilidad a hipertemia maligna
Present status of the susceptibility to malignant hyperthermia
Rev. chil. anest; 26 (2), 1997